Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niazi, S.
Right arrow Articles by Zangrilli, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niazi, S.
Right arrow Articles by Zangrilli, J.
(Chest. 2003;123:345S.)
© 2003 American College of Chest Physicians

Overlap Between Death Receptor and Non-Receptor-Mediated Mechanisms During Apoptosis in Human Eosinophils*

Sultan Niazi, MD; Noreen M. Robertson, DMD; Ashish Agrawal, MD; Annette T. Hastie, PhD; Stephen P. Peters, MD, PhD, FCCP and James Zangrilli, MD, FCCP

* From the Thomas Jefferson University Hospital, Philadelphia, PA.

Correspondence to: James Zangrilli, MD, FCCP, Thomas Jefferson University, Rm 805, College Bldg, 1025 Walnut St, Philadelphia, PA 19107; e-mail: james.zangrilli{at}mail.tju.edu


    Introduction
 TOP
 Introduction
 Materials and Methods
 Results
 Conclusion
 References
 
Eosinophils undergo spontaneous apoptosis in the absence of specific cytokines, which is further accelerated by Fas engagement and glucocorticoids. We have previously shown that interleukin (IL)-5 profoundly affects the processing of caspase 3 in eosinophils, a downstream executioner of apoptosis, but the level of inhibition is unclear.1 We hypothesized that IL-5 would affect the kinetics of receptor-mediated apoptosis vs non-receptor-mediated apoptosis differently and that this would be reflected by differential activation of elements presumed to be unique to these pathways.


    Materials and Methods
 TOP
 Introduction
 Materials and Methods
 Results
 Conclusion
 References
 
Human peripheral blood eosinophils were cultured in media alone (control), IL-5 (1 ng/mL), dexamethasone (Dex; 1 µmol/L), or agonist anti-Fas antibody (500 ng/mL). Viability by trypan, and the processing of caspases 8, 9, and the apoptosis regulatory protein Bid by immunoblot assay were determined at 8, 24, and 48 h. Bid also was examined in fixed eosinophils by immunochemistry.


    Results
 TOP
 Introduction
 Materials and Methods
 Results
 Conclusion
 References
 
Anti-Fas and Dex accelerated cell death compared to media alone. IL-5 blocked Dex-induced cell death and slowed cell death induced by anti-Fas. Caspase 8, 9, and Bid processing occurred during both anti-Fas and Dex treatment. Bid was processed to a similar extent during both anti-Fas and Dex stimulation. Furthermore, Dex treatment caused an early shift in cellular Bid staining from its baseline diffuse cytoplasmic pattern to an increasingly punctate one.


    Conclusion
 TOP
 Introduction
 Materials and Methods
 Results
 Conclusion
 References
 
Caspases 8, 9, and Bid were processed efficiently in the absence of obvious activation of the Fas receptor, suggesting alternative mechanisms for caspase 8 activation. IL-5 had the ability to modulate the caspase activation at several levels.


    Footnotes
 
Abbreviations: Dex = dexamethasone; IL = interleukin

This research was supported by National Institutes of Health grants HL03663 and AI24509, and by the Merck Young Investigator Award.


    References
 TOP
 Introduction
 Materials and Methods
 Results
 Conclusion
 References
 

  1. Zangrilli, J, Robertson, N, Shetty, A, et al (2000) Effect of IL-5 glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils. Clin Exp Immunol 120,12-21[CrossRef][Medline]




This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niazi, S.
Right arrow Articles by Zangrilli, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niazi, S.
Right arrow Articles by Zangrilli, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS